Martine Cohen-Salmon

Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death.

Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential.

Expression of the connexin43- and connexin45-encoding genes in the developing and mature mouse inner ear.

Hearing the messenger: Ins(1,4,5)P3 and deafness.

[Ins(1,4,5)P3: a messenger for hearing].

Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis.

Consortin, a trans-Golgi network cargo receptor for the plasma membrane targeting and recycling of connexins.

Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro-inflammatory treatments.

Deletion of astroglial connexins weakens the blood-brain barrier.

Bmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions.

Bmcc1s interacts with the phosphate-activated glutaminase in the brain.

Hearing is normal without connexin30.

Connexin 30 sets synaptic strength by controlling astroglial synapse invasion.

The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels.

Immune quiescence of the brain is set by astroglial connexin 43.